Setting occupational exposure limits for pharmaceuticals

B D Naumann; E V Sargent

Setting occupational exposure limits for pharmaceuticals

Occup Med. 1997 Jan-Mar;12(1):67-80.

Authors

B D Naumann¹, E V Sargent

Affiliation

¹ Merck & Co., Inc. Whitehouse Station, New Jersey 08889-0100, USA.

PMID: 9153053

Abstract

The active ingredients used in the pharmaceutical industry's products are designed to modify biological processes; thus, if not adequately controlled, they can place employees at risk. This chapter provides an historical look at the need for occupational exposure limits, as well as an overview of the limit-setting process.

Publication types

Review

MeSH terms

Animals
Biological Availability
Clinical Trials as Topic / standards
Communication
Documentation
Drug Industry / standards*
Environmental Monitoring / methods
Hazardous Substances* / pharmacokinetics
Humans
Maximum Allowable Concentration
No-Observed-Adverse-Effect Level
Occupational Diseases / prevention & control*
Occupational Exposure / legislation & jurisprudence
Occupational Exposure / standards*
Occupational Health*
Risk Assessment
Species Specificity
Toxicity Tests / standards*
United States

Substances

Hazardous Substances